Northpond Ventures: Investment Portfolio & Startup News

AI Search

Announce News

Northpond Ventures

To add a bio or update investment portfolio click update information.

Investment Portfolio

Mestag Therapeutics

16 Mar 2026

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

Mestag Therapeutics develops antibody treatments based on fibroblast immunology for cancer and inflammatory diseases. It is building therapies designed to direct and drive immune responses using fibroblast-immune biology.

Northpond Ventures

- Life Sciences
1(12 months)
npv.vc
Update Information

More venture news

Zenithon
30 Sept 2026
Zenithon raises a £7.5m seed round led by BACKED for ML models that solves complex physics
EquityDeep Tech
Inovus Medical
30 Sept 2026
Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
EquityHealth
Something & Nothing
29 Sept 2026
Something & Nothing unlocks £5m in funding led by Venrex for premium soft drinks built on flavour
EquityConsumer

Northpond Ventures: Investment Portfolio & Startup News

Investment Portfolio

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

More venture news

Zenithon raises a £7.5m seed round led by BACKED for ML models that solves complex physics

Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training

Something & Nothing unlocks £5m in funding led by Venrex for premium soft drinks built on flavour